One of the key mechanisms of TNF-α in breast cancer involves its ability to promote tumor growth by upregulating the oncogenic protein hepatitis B X-interacting protein (HBXIP), thereby enhancing cell proliferation and survival. Here, LAMTOR5 is linked to breast cancer.